Holding released a new polygenic risk score report on the genetics of osteoporosis for 23andMe+ Premium members. The report ...
23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter ...
At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.
The struggling genetic-testing 23andMe is looking for a buyer for the virtual-care business it acquired in 2021, Business ...
23andMe Holding Co. ( ME, Financials) announced that its board's Special Committee is reviewing strategic alternatives, ...
But there are facts, law and precedent on point, which are worth examining. First, we can start with 23andMe’s privacy statement, which is—to their credit—strong. In general, data can be ...
Me (ME) ended December 31, 2024 with cash and cash equivalents of $79.4M, compared to $126.6M as of September 30, 2024 and $216.5M as of ...